OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effectiveness of Oral Nirmatrelvir/Ritonavir vs. Intravenous Three-Day Remdesivir in Preventing Progression to Severe COVID-19: A Single-Center, Prospective, Comparative, Real-Life Study
Dimitrios Basoulis, Aristeidis Tsakanikas, Aikaterini Gkoufa, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1515-1515
Open Access | Times Cited: 11
Dimitrios Basoulis, Aristeidis Tsakanikas, Aikaterini Gkoufa, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1515-1515
Open Access | Times Cited: 11
Showing 11 citing articles:
A mid‑pandemic night's dream: Melatonin, from harbinger of anti‑inflammation to mitochondrial savior in acute and long COVID‑19 (Review)
Ioannis Lempesis, Vasiliki Georgakopoulou, Russel J. Reıter, et al.
International Journal of Molecular Medicine (2024) Vol. 53, Iss. 3
Open Access | Times Cited: 5
Ioannis Lempesis, Vasiliki Georgakopoulou, Russel J. Reıter, et al.
International Journal of Molecular Medicine (2024) Vol. 53, Iss. 3
Open Access | Times Cited: 5
Joint analysis of vaccination effectiveness and antiviral drug effectiveness for COVID-19: a causal inference approach
Yue Yat Harrison Cheung, Eric H. Y. Lau, Guosheng Yin, et al.
International Journal of Infectious Diseases (2024) Vol. 143, pp. 107012-107012
Open Access | Times Cited: 5
Yue Yat Harrison Cheung, Eric H. Y. Lau, Guosheng Yin, et al.
International Journal of Infectious Diseases (2024) Vol. 143, pp. 107012-107012
Open Access | Times Cited: 5
Does early combination vs. Monotherapy improve clinical outcomes of clinically extremely vulnerable patients with COVID-19? Results from a retrospective propensity-weighted analysis
Maria Mazzitelli, Alberto Enrico Maraolo, Claudia Cozzolino, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 5
Maria Mazzitelli, Alberto Enrico Maraolo, Claudia Cozzolino, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 5
Protection and waning of vaccine-induced, natural and hybrid immunity to SARS-CoV-2 in Hong Kong
Jialiang Jiang, Kwok Fai Lam, Eric H. Y. Lau, et al.
Expert Review of Vaccines (2025)
Open Access
Jialiang Jiang, Kwok Fai Lam, Eric H. Y. Lau, et al.
Expert Review of Vaccines (2025)
Open Access
Executive summary of the consensus statement of the group for the study of infection in transplantation and other immunocompromised host (GESITRA-IC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the treatment of SARS-CoV-2 infection in solid organ transplant recipients
Sabina Herrera, José María Aguado, Francisco Javier Candel, et al.
Transplantation Reviews (2023) Vol. 37, Iss. 4, pp. 100788-100788
Closed Access | Times Cited: 8
Sabina Herrera, José María Aguado, Francisco Javier Candel, et al.
Transplantation Reviews (2023) Vol. 37, Iss. 4, pp. 100788-100788
Closed Access | Times Cited: 8
Clinical Manifestations and Outcomes of Older Patients with COVID-19: A Comprehensive Review
Jeong Eun Lee, Da Hyun Kang, Soyun Kim, et al.
Tuberculosis & respiratory diseases (2024) Vol. 87, Iss. 2, pp. 145-154
Open Access | Times Cited: 2
Jeong Eun Lee, Da Hyun Kang, Soyun Kim, et al.
Tuberculosis & respiratory diseases (2024) Vol. 87, Iss. 2, pp. 145-154
Open Access | Times Cited: 2
Nirmatrelvir/ritonavir and remdesivir against symptomatic treatment in high-risk COVID-19 outpatients to prevent hospitalization or death during the Omicron era: a propensity score-matched study
Sandra Rajme‐López, Bernardo Alfonso Martínez-Guerra, Carla Marina Román-Montes, et al.
Therapeutic Advances in Infectious Disease (2024) Vol. 11
Open Access | Times Cited: 2
Sandra Rajme‐López, Bernardo Alfonso Martínez-Guerra, Carla Marina Román-Montes, et al.
Therapeutic Advances in Infectious Disease (2024) Vol. 11
Open Access | Times Cited: 2
Antiviral treatment for SARS-CoV-2 infection in the current situation: a position paper of the Spanish Society of Emergency Medicine (SEMES)
Juan González del Castillo, Amparo Fernández-Simón Almela, Javier Jacob, et al.
Emergencias (2024)
Open Access | Times Cited: 1
Juan González del Castillo, Amparo Fernández-Simón Almela, Javier Jacob, et al.
Emergencias (2024)
Open Access | Times Cited: 1
Nirmatrelvir/ritonavir for COVID-19: an overview of systematic reviews
Mario Cruciani, Ilaria Pati, Francesca Masiello, et al.
Journal of Antimicrobial Chemotherapy (2023) Vol. 79, Iss. 3, pp. 477-497
Closed Access | Times Cited: 2
Mario Cruciani, Ilaria Pati, Francesca Masiello, et al.
Journal of Antimicrobial Chemotherapy (2023) Vol. 79, Iss. 3, pp. 477-497
Closed Access | Times Cited: 2
Neutralizing monoclonal antibodies for the prevention of severe COVID-19: a retrospective study during Omicron BA.1 variant surge
Claudia Bartalucci, Alessandro Limongelli, Laura Ambra Nicolini, et al.
Journal of Chemotherapy (2023) Vol. 36, Iss. 4, pp. 283-290
Closed Access | Times Cited: 1
Claudia Bartalucci, Alessandro Limongelli, Laura Ambra Nicolini, et al.
Journal of Chemotherapy (2023) Vol. 36, Iss. 4, pp. 283-290
Closed Access | Times Cited: 1
Integrated Analysis of Remdesivir and Paxlovid in COVID-19 Patients: A Personalized Approach to High-Risk Individuals for Severe Evolution
Andreea Fitero, Nicoleta Negruț, Anca Popa, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 22, pp. 6670-6670
Open Access
Andreea Fitero, Nicoleta Negruț, Anca Popa, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 22, pp. 6670-6670
Open Access
